Literature DB >> 2174557

Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen.

P N Friedman1, S E Kern, B Vogelstein, C Prives.   

Abstract

Murine p53 blocks many of the replication activities of simian virus 40 (SV40) large tumor antigen (T antigen) in vitro. As murine cells do not replicate SV40 DNA, it was of interest to determine how p53 from permissive human cells functions. Recombinant baculoviruses encoding either the wild-type form of human p53 or a mutant p53 cloned from a human tumor cell line were constructed, and p53 proteins were purified from infected insect cells. Surprisingly, we found that wild-type human p53 was as inhibitory to the ability of T antigen to mediate replication of an SV40 origin-containing (ori DNA) plasmid in vitro as was murine p53. Wild-type human p53 also blocked the DNA unwinding activity of T antigen, as did its murine counterpart. In contrast to murine and wild-type human p53, the mutant human p53 did not block ori DNA replication or DNA unwinding. Murine p53 formed a complex with mutant human p53 in vivo. Furthermore, mutant human p53 reduced the inhibition of SV40 ori DNA replication by murine p53 in vitro. These results provide a model for the way in which mutant p53 proteins can affect normal functions of p53.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174557      PMCID: PMC55147          DOI: 10.1073/pnas.87.23.9275

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Biological and molecular analysis of p53 cellular-encoded tumor antigen.

Authors:  V Rotter; D Wolf
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

2.  Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53.

Authors:  J R Jenkins; K Rudge; S Redmond; A Wade-Evans
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

3.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus.

Authors:  M Mowat; A Cheng; N Kimura; A Bernstein; S Benchimol
Journal:  Nature       Date:  1985 Apr 18-24       Impact factor: 49.962

4.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

5.  Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.

Authors:  E Harlow; N M Williamson; R Ralston; D M Helfman; T E Adams
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

6.  Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells.

Authors:  E Harlow; D C Pim; L V Crawford
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

7.  Simian virus 40 DNA replication in vitro.

Authors:  J J Li; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Characterization of human p53 antigens employing primate specific monoclonal antibodies.

Authors:  R Thomas; L Kaplan; N Reich; D P Lane; A J Levine
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

9.  Analysis of the gene coding for the murine cellular tumour antigen p53.

Authors:  B Bienz; R Zakut-Houri; D Givol; M Oren
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

10.  Radioimmunoassay of the cellular protein p53 in mouse and human cell lines.

Authors:  S Benchimol; D Pim; L Crawford
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  38 in total

1.  Replication of damaged DNA in vitro is blocked by p53.

Authors:  Jianmin Zhou; Carol Prives
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

Review 2.  Cell cycle control of initiation of eukaryotic DNA replication.

Authors:  J A Huberman
Journal:  Chromosoma       Date:  1991-08       Impact factor: 4.316

3.  Mammalian p53 can function as a transcription factor in yeast.

Authors:  E Schärer; R Iggo
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

4.  A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis.

Authors:  P Friedlander; Y Haupt; C Prives; M Oren
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation.

Authors:  M E Anderson; B Woelker; M Reed; P Wang; P Tegtmeyer
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

6.  Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin.

Authors:  Yira Bermudez; Steven P Stratton; Clara Curiel-Lewandrowski; James Warneke; Chengcheng Hu; George T Bowden; Sally E Dickinson; Zigang Dong; Ann M Bode; Kathylynn Saboda; Christine A Brooks; Emanuel F Petricoin; Craig A Hurst; David S Alberts; Janine G Einspahr
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-01

7.  Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Authors:  Eung-Soo Hwang; Zhigang Zhang; Haobin Cai; David Y Huang; Shu-Mei Huong; Chang-Yong Cha; Eng-Shang Huang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

8.  Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.

Authors:  P K Liu; E Kraus; T A Wu; L C Strong; M A Tainsky
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

9.  Inhibition of viral and cellular promoters by human wild-type p53.

Authors:  M A Subler; D W Martin; S Deb
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.

Authors:  S Deb; C T Jackson; M A Subler; D W Martin
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.